DepoCyte recall in EU, continued access required in some countries

Source: Reactions Weekly, Volume 1, Number 1417, 2012-09-01 , pp. 3-3(1)

Publisher: Adis International

Keywords: Cytarabine, adverse reactions; Pharmacovigilance; Therapeutic-product-contamination

Document Type: Short communication

Publication date: 2012-01-01

• In this: publication
• By this: publisher
• In this Subject: Pharmacology

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers